These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12587108)

  • 1. Solid-state nuclear magnetic resonance spectroscopy--pharmaceutical applications.
    Tishmack PA; Bugay DE; Byrn SR
    J Pharm Sci; 2003 Mar; 92(3):441-74. PubMed ID: 12587108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of solid-state NMR in pharmaceutical analysis.
    Vogt FG
    Future Med Chem; 2010 Jun; 2(6):915-21. PubMed ID: 21426109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Solid-state NMR spectroscopy and its pharmaceutical use].
    Marosi A; Szalay Z; Demeter A
    Acta Pharm Hung; 2010; 80(1):18-45. PubMed ID: 20443364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of qualitative and quantitative analysis methods in pharmaceutical application with new selective signal excitation methods for 13 C solid-state nuclear magnetic resonance using 1 H T1rho relaxation time.
    Nasu M; Nemoto T; Mimura H; Sako K
    J Pharm Sci; 2013 Jan; 102(1):154-61. PubMed ID: 23147444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terahertz pulsed spectroscopy and imaging in the pharmaceutical setting--a review.
    Zeitler JA; Taday PF; Newnham DA; Pepper M; Gordon KC; Rades T
    J Pharm Pharmacol; 2007 Feb; 59(2):209-23. PubMed ID: 17270075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid-state NMR studies of pharmaceutical solids in polymer matrices.
    Lubach JW; Padden BE; Winslow SL; Salsbury JS; Masters DB; Topp EM; Munson EJ
    Anal Bioanal Chem; 2004 Mar; 378(6):1504-10. PubMed ID: 15214410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of compaction-induced crystallinity reduction of a pharmaceutical solid using 19F solid-state NMR and powder X-ray diffraction.
    Liu J; Nagapudi K; Kiang YH; Martinez E; Jona J
    Drug Dev Ind Pharm; 2009 Aug; 35(8):969-75. PubMed ID: 19360510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-state NMR in the analysis of drugs and naturally occurring materials.
    Paradowska K; Wawer I
    J Pharm Biomed Anal; 2014 May; 93():27-42. PubMed ID: 24173236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of low-level PTFE contamination: An application of solid-state NMR to structure elucidation in the pharmaceutical industry.
    Pham TN; Day CJ; Edwards AJ; Wood HR; Lynch IR; Watson SA; Bretonnet AS; Vogt FG
    J Pharm Biomed Anal; 2011 Jan; 54(2):401-5. PubMed ID: 20880648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of solid-state NMR to pharmaceutical polymorphism and related matters.
    Harris RK
    J Pharm Pharmacol; 2007 Feb; 59(2):225-39. PubMed ID: 17270076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of a polymorphic mixture of an active pharmaceutical ingredient with solid state (13)C CPMAS NMR spectroscopy.
    Virtanen T; Maunu SL
    Int J Pharm; 2010 Jul; 394(1-2):18-25. PubMed ID: 20416365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical impurity identification: a case study using a multidisciplinary approach.
    Alsante KM; Boutros P; Couturier MA; Friedmann RC; Harwood JW; Horan GJ; Jensen AJ; Liu Q; Lohr LL; Morris R; Raggon JW; Reid GL; Santafianos DP; Sharp TR; Tucker JL; Wilcox GE
    J Pharm Sci; 2004 Sep; 93(9):2296-309. PubMed ID: 15295790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of REDOR NMR in natural product chemistry.
    Matsuoka S; Inoue M
    Chem Commun (Camb); 2009 Oct; (38):5664-75. PubMed ID: 19774235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in the quantitative analytical methods of drug polymorphism].
    Ma LW; Du W; Zhao CS
    Yao Xue Xue Bao; 2011 Aug; 46(8):896-903. PubMed ID: 22007512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinguishing anhydrous and hydrous forms of an active pharmaceutical ingredient in a tablet formulation using solid-state NMR spectroscopy.
    Griffin JM; Martin DR; Brown SP
    Angew Chem Int Ed Engl; 2007; 46(42):8036-8. PubMed ID: 17847137
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy.
    Heinz A; Strachan CJ; Gordon KC; Rades T
    J Pharm Pharmacol; 2009 Aug; 61(8):971-88. PubMed ID: 19703341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved solid-state NMR quantifications of active principles in pharmaceutical formulations.
    Sanchez S; Ziarelli F; Viel S; Delaurent C; Caldarelli S
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):683-7. PubMed ID: 18479881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of electrical tomographic measurements in pharmaceutical and related application areas.
    Bolton GT; Primrose KM
    AAPS PharmSciTech; 2005 Sep; 6(2):E137-43. PubMed ID: 16353970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the solid-state: spectroscopic techniques.
    Bugay DE
    Adv Drug Deliv Rev; 2001 May; 48(1):43-65. PubMed ID: 11325476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-state nuclear magnetic resonance spectroscopy: theory and pharmaceutical applications.
    Bugay DE
    Pharm Res; 1993 Mar; 10(3):317-27. PubMed ID: 8464803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.